Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4741)
All Articles published online
|
Apr 21, 2011 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu SJ, Yu JK, Ge WT, Hu HG, Yuan Y, Zheng S. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer. World J Gastroenterol 2011; 17(15): 2028-2036 [PMID: 21528083 DOI: 10.3748/wjg.v17.i15.2028] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i15/2028.htm |
| Number | Citing Articles |
| 1 |
Angeliki Kotti, Annica Holmqvist, Maria Albertsson, Xiao-Feng Sun. SPARCL1 Expression Increases With Preoperative Radiation Therapy and Predicts Better Survival in Rectal Cancer Patients. International Journal of Radiation Oncology*Biology*Physics 2014; 88(5): 1196 doi: 10.1016/j.ijrobp.2013.12.041
|
| 2 |
Jason M. Conley, Cameron S. Brand, Amy S. Bogard, Evan P. S. Pratt, Ruqiang Xu, Gregory H. Hockerman, Rennolds S. Ostrom, Carmen W. Dessauer, Val J. Watts. Development of a High-Throughput Screening Paradigm for the Discovery of Small-Molecule Modulators of Adenylyl Cyclase: Identification of an Adenylyl Cyclase 2 Inhibitor. Journal of Pharmacology and Experimental Therapeutics 2013; 347(2): 276 doi: 10.1124/jpet.113.207449
|
| 3 |
Peng-Ying Wang, Shihui Yang, Yun-Juan Bao. An Integrative Analysis Framework for Identifying the Prognostic Markers from Multidimensional RNA Data of Clear Cell Renal Cell Carcinoma. The American Journal of Pathology 2022; 192(4): 671 doi: 10.1016/j.ajpath.2021.12.009
|
| 4 |
Chuan Chen, Mengmeng Cao, Siyu Zhu, Cuicui Wang, Fan Liang, Leilei Yan, Duqiang Luo. Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2. Scientific Reports 2015; 5(1) doi: 10.1038/srep17626
|
| 5 |
Huaqin Yuan, Jun Zhao, Yang Yang, Rongfu Wei, Liangxue Zhu, Jie Wang, Meiqing Ding, Mingyun Wang, Yanhong Gu. SHP-2 Interacts with CD81 and Regulates the Malignant Evolution of Colorectal Cancer by Inhibiting Epithelial–Mesenchymal Transition. Cancer Management and Research 2020; : 13273 doi: 10.2147/CMAR.S270813
|
| 6 |
Xiaolei Gao, Na Zhao, Liying Dong, Xuan Zheng, Yixin Zhang, Chong Ding, Shuyan Zhao, Zeyun Ma, Yixiang Wang. A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.735993
|
| 7 |
Yide Huang, Yafei Zhang, Lilin Ge, Yao Lin, Hang Kwok. The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma. Cancers 2018; 10(3): 82 doi: 10.3390/cancers10030082
|
| 8 |
Min-Kyung Kim, Jee Young Park, Yu Na Kang. Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo. Pathology - Research and Practice 2018; 214(7): 1031 doi: 10.1016/j.prp.2018.04.010
|
| 9 |
Xibo Liu, Mengyao Li, Lirong Chen, Fei Wen, Shu Zheng, Weiting Ge. High expression of SHP2 predicts a promising prognosis in colorectal cancer. Indian Journal of Pathology and Microbiology 2024; 67(1): 29 doi: 10.4103/ijpm.ijpm_894_22
|
| 10 |
Jian-Hong Peng, Yu-Jing Fang, Cai-Xia Li, Qing-Jian Ou, Wu Jiang, Shi-Xun Lu, Zhen-Hai Lu, Pei-Xing Li, Jing-Ping Yun, Rong-Xin Zhang, Zhi-Zhong Pan, De-Sen Wan. A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery. Oncotarget 2016; 7(16): 22939 doi: 10.18632/oncotarget.8217
|
| 11 |
HUI-YOUNG LEE, SEON-SOOK HAN, HWANSEOK RHEE, JUNG HOON PARK, JAE SEUNG LEE, YEON-MOK OH, SUN SHIM CHOI, SEUNG-HO SHIN, WOO JIN KIM. Differential expression of microRNAs and their target genes in non-small-cell lung cancer. Molecular Medicine Reports 2015; 11(3): 2034 doi: 10.3892/mmr.2014.2890
|
| 12 |
Bikash Chandra Jena, Daniel P. Flaherty, Valerie P. O'Brien, Val J. Watts. Biochemical pharmacology of adenylyl cyclases in cancer. Biochemical Pharmacology 2024; : 116160 doi: 10.1016/j.bcp.2024.116160
|
| 13 |
TOSHIYUKI TANAHASHI, SHINJI OSADA, ATSUKO YAMADA, JUNKO KATO, KAZUNORI YAWATA, RYUTARO MORI, HISASHI IMAI, YOSHIYUKI SASAKI, SHIRO SAITO, YOSHIHIRO TANAKA, KENICHI NONAKA, KAZUHIRO YOSHIDA. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition. International Journal of Oncology 2013; 42(2): 556 doi: 10.3892/ijo.2012.1726
|
| 14 |
Bapi Gorain, Hira Choudhury, Gan Sook Yee, Subrat Kumar Bhattamisra. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers. Current Pharmaceutical Design 2019; 25(26): 2828 doi: 10.2174/1381612825666190716102037
|
| 15 |
Syeda Zahra Abbas, Muhammad Imran Qadir, Syed Aun Muhammad. Systems-level differential gene expression analysis reveals new genetic variants of oral cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71346-7
|
| 16 |
FUQIANG YIN, XIA LIU, DANRONG LI, QI WANG, WEI ZHANG, LI LI. Bioinformatic analysis of chemokine (C-C motif) ligand 21 and SPARC-like protein 1 revealing their associations with drug resistance in ovarian cancer. International Journal of Oncology 2013; 42(4): 1305 doi: 10.3892/ijo.2013.1819
|
| 17 |
Yi‐Ting Chen, Chun‐Chieh Wu, Xuan‐Ping Liu, Chee‐Yin Chai. Aberrant β‐catenin expression in urothelial carcinomas in blackfoot disease‐endemic areas. The Kaohsiung Journal of Medical Sciences 2017; 33(1): 11 doi: 10.1016/j.kjms.2016.10.006
|
| 18 |
Archanalakshmi Kambaru, Nidhee Chaudhary. Role of Protein Tyrosine Phosphatase in Regulation of Cell Signaling Cascades Affecting Tumor Cell Growth: A Future Perspective as Anti-Cancer Drug Target. Current Pharmaceutical Biotechnology 2022; 23(7): 920 doi: 10.2174/1389201022666210810094739
|
| 19 |
Hung-Chia Chen, James J. Chen. Hybrid Mixture Model for Subpopulation Identification. Statistics in Biosciences 2016; 8(1): 28 doi: 10.1007/s12561-015-9131-y
|
| 20 |
Björg Kristjansdottir, Kristina Levan, Karolina Partheen, Elisabet Carlsohn, Karin Sundfeldt. Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ. Clinical Proteomics 2013; 10(1) doi: 10.1186/1559-0275-10-4
|
| 21 |
JIN-LAI WEI, ZHONG-XUE FU, MIN FANG, JIN-BAO GUO, QING-NING ZHAO, WEI-DONG LU, QIU-YUAN ZHOU. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer. Oncology Reports 2015; 33(3): 1349 doi: 10.3892/or.2014.3701
|
| 22 |
FUGUO LIU, FENGZHI JI, YULING JI, YUEPING JIANG, XUEGUO SUN, YANYAN LU, LINGYUN ZHANG, YUE HAN, XISHUANG LIU. In-depth analysis of the critical genes and pathways in colorectal cancer. International Journal of Molecular Medicine 2015; 36(4): 923 doi: 10.3892/ijmm.2015.2298
|
| 23 |
Wei Han, Fang Cao, Wei Ding, Xiao‑Jiao Gao, Fang Chen, Yong‑Wei Hu, Hou‑Zhong Ding. Prognostic value of SPARCL1 in patients with colorectal cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7511
|
| 24 |
Takafumi Nobuchi, Tomoaki Saito, Atsushi Kasamatsu, Kohei Kawasaki, Ryunosuke Nozaki, Yutaro Kase, Manabu Iyoda, Masayoshi Saito, Takashi Uno, Katsuhiro Uzawa. Assay for transposase-accessible chromatin with high-throughput sequencing reveals radioresistance-related genes in oral squamous cell carcinoma cells. Biochemical and Biophysical Research Communications 2022; 597: 115 doi: 10.1016/j.bbrc.2022.01.122
|
| 25 |
Seung-Hyun Hong, Sung-Ho Goh, Sang Jin Lee, Jung-Ah Hwang, Jieun Lee, Il-Ju Choi, Hyehyun Seo, Jong-Hoon Park, Hiromu Suzuki, Eiichiro Yamamoto, In-Hoo Kim, Jin Sook Jeong, Mi Ha Ju, Dong-Hee Lee, Yeon-Su Lee. Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway. Oncotarget 2013; 4(10): 1791 doi: 10.18632/oncotarget.1324
|
| 26 |
Zi-jun Xu, Ji-chun Ma, Jing-dong Zhou, Xiang-mei Wen, Dong-ming Yao, Wei Zhang, Run-bi Ji, De-hong Wu, Li-juan Tang, Zhao-qun Deng, Jun Qian, Jiang Lin. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1851-1
|
| 27 |
Y. X. Li, H. G. Jin, C. G. Yan, C. Y. Ren, C. J. Jiang, C. D. Jin, K. S. Seo, X. Jin. Molecular cloning, sequence identification, and gene expression analysis of bovine ADCY2 gene. Molecular Biology Reports 2014; 41(6): 3561 doi: 10.1007/s11033-014-3167-9
|
| 28 |
Hui Ye, Wei-Gang Wang, Jun Cao, Xi-Chun Hu. SPARCL1 suppresses cell migration and invasion in renal cell carcinoma. Molecular Medicine Reports 2017; 16(5): 7784 doi: 10.3892/mmr.2017.7535
|
| 29 |
Chengying Jiang, Fangke Hu, Yanhong Tai, Jingli Du, Beibei Mao, Zengqiang Yuan, Yan Wang, Lixin Wei. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2012; 138(4): 637 doi: 10.1007/s00432-011-1143-5
|
| 30 |
Peifen Cai, Wenjie Guo, HuaQin Yuan, Qian Li, Weicheng Wang, Yang Sun, Xiaomin Li, Yanhong Gu. Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer. Biomedicine & Pharmacotherapy 2014; 68(3): 285 doi: 10.1016/j.biopha.2013.10.012
|
| 31 |
Ting Li, Xia Liu, Antai Yang, Wenjie Fu, Fuqiang Yin, Xiaoyun Zeng. Associations of tumor suppressor SPARCL1 with cancer progression and prognosis. Oncology Letters 2017; 14(3): 2603 doi: 10.3892/ol.2017.6546
|
| 32 |
Geneviève Coulombe, Nathalie Rivard. New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract. Cellular and Molecular Gastroenterology and Hepatology 2016; 2(1): 11 doi: 10.1016/j.jcmgh.2015.11.001
|
| 33 |
Kazuya Shinmura, Masanori Goto, Masaya Suzuki, Hong Tao, Hidetaka Yamada, Hisaki Igarashi, Shun Matsuura, Matsuyoshi Maeda, Hiroyuki Konno, Tomonari Matsuda, Haruhiko Sugimura. Reduced expression of MUTYH with suppressive activity against mutations caused by 8‐hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer. The Journal of Pathology 2011; 225(3): 414 doi: 10.1002/path.2953
|
| 34 |
Cristina Santos, Eduardo Vilar, Gabriel Capella, Ramon Salazar. Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer. Colorectal Cancer 2013; 2(3): 243 doi: 10.2217/crc.13.24
|
| 35 |
Xuan Wei, Wencheng Hu, Kexi Mao. A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer. Medicine 2023; 102(5): e32766 doi: 10.1097/MD.0000000000032766
|
| 36 |
Hanguang Hu, Hang Zhang, Weiting Ge, Xiyong Liu, Sofia Loera, Peiguo Chu, Huarong Chen, Jiaping Peng, Lun Zhou, Shujing Yu, Ying Yuan, Suzhan Zhang, Lily Lai, Yun Yen, Shu Zheng.
Secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers. Clinical Cancer Research 2012; 18(19): 5438 doi: 10.1158/1078-0432.CCR-12-0124
|
| 37 |
Rui-Rui Wang, Wen-Shan Liu, Liang Zhou, Ying Ma, Run-Ling Wang. Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamics. Journal of Biomolecular Structure and Dynamics 2020; 38(5): 1525 doi: 10.1080/07391102.2019.1613266
|
| 38 |
Yuzhu Xiang, Qingchao Qiu, Ming Jiang, Renjie Jin, Brian D. Lehmann, Douglas W. Strand, Bojana Jovanovic, David J. DeGraff, Yi Zheng, Dina A. Yousif, Christine Q. Simmons, Thomas C. Case, Jia Yi, Justin M. Cates, John Virostko, Xiusheng He, Xunbo Jin, Simon W. Hayward, Robert J. Matusik, Alfred L. George, Yajun Yi. SPARCL1 suppresses metastasis in prostate cancer. Molecular Oncology 2013; 7(6): 1019 doi: 10.1016/j.molonc.2013.07.008
|
| 39 |
Si-Liang Chen, Fang Hu, Da-Wei Wang, Zhe-Yuan Qin, Yang Liang, Yu-Jun Dai. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia. Aging 2020; 12(12): 11864 doi: 10.18632/aging.103357
|
| 40 |
Wenjun Chang, Xianhua Gao, Yifang Han, Yan Du, Qizhi Liu, Lei Wang, Xiaojie Tan, Qi Zhang, Yan Liu, Yan Zhu, Yongwei Yu, Xinjuan Fan, Hongwei Zhang, Weiping Zhou, Jianping Wang, Chuangang Fu, Guangwen Cao. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma. Gut 2014; 63(9): 1457 doi: 10.1136/gutjnl-2013-305475
|
| 41 |
Sierra N. Quinn, Sarai H. Graves, Clayton Dains‐McGahee, Emilee M. Friedman, Humma Hassan, Piotr Witkowski, Maria E. Sabbatini. Adenylyl cyclase 3/adenylyl cyclase‐associated protein 1 (CAP1) complex mediates the anti‐migratory effect of forskolin in pancreatic cancer cells. Molecular Carcinogenesis 2017; 56(4): 1344 doi: 10.1002/mc.22598
|
| 42 |
Shinji Osada, Hisashi Imai, Yoshiyuki Sasaki, Kazuhiro Yoshida. Strategies for Synchronous and Multiple Metastatic Liver Tumors Designed from Epithelial-Mesenchymal Transition Concept. Journal of Cancer Therapy 2012; 3(03): 201 doi: 10.4236/jct.2012.33029
|
| 43 |
Jing Chen, Xu Zhao, Yuan Yuan, Jing-Jing Jing. The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01315-7
|
| 44 |
Liang Zhou, Yong Feng, Yang-Chun Ma, Zhao Zhang, Jing-Wei Wu, Shan Du, Wei-Ya Li, Xin-Hua Lu, Ying Ma, Run-Ling Wang. Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 WT and SHP2F285S by molecular dynamics study. Journal of Molecular Graphics and Modelling 2021; 103: 107807 doi: 10.1016/j.jmgm.2020.107807
|
| 45 |
Ruth Zhen Li, Jing Hou, Yaxun Wei, Xiaotian Luo, Yali Ye, Yi Zhang. hnRNPDL extensively regulates transcription and alternative splicing. Gene 2019; 687: 125 doi: 10.1016/j.gene.2018.11.026
|